首页> 外文期刊>Annals of surgical oncology >Thyroidectomy as primary treatment optimizes body mass index in patients with hyperthyroidism
【24h】

Thyroidectomy as primary treatment optimizes body mass index in patients with hyperthyroidism

机译:甲状腺切除术作为甲亢患者的主要治疗手段可优化体重指数

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: The purpose of this study was to determine how the timing of thyroidectomy influenced postoperative weight change. Methods: We conducted a two-institution study, identifying patients treated with total thyroidectomy for hyperthyroidism. Patients were classified as 'early' if they were referred for surgery as the first treatment option, or 'delayed' if they were previously treated with radioactive iodine (RAI). Groups were compared with the Student's t-test or χ 2 test where appropriate. Results: There were 204 patients undergoing thyroidectomy for hyperthyroidism. Of these, 171 patients were classified as early and 33 were classified as delayed. Overall, patients gained 6.0 % ±0.8 of their preoperative body weight at last follow-up. Preoperative body mass indexes (BMIs) were similar between groups (p = 0.98), and the median follow-up time was 388 days (range 15-1,584 days). Both groups gained weight until they achieved a normal thyroid-stimulating hormone (TSH) postoperatively. After achieving a normal TSH, the early group stabilized or lost weight (-0.2 lbs/day), while the delayed group continued to gain weight (0.02 lbs/day; p = 0.61). At last follow-up, there were significantly more patients in the delayed group who increased their BMI category compared with the early group (42.4 vs. 21.6 %; p = 0.01). Twice as many patients in the delayed group moved up or into an unhealthy BMI category (overweight or obese) compared with the early group (39.4 vs. 19.3 %; p = 0.01). Conclusions: Compared with patients initially treated with RAI, patients with hyperthyroidism who underwent surgery as the first treatment were less likely to become overweight or obese postoperatively.
机译:目的:本研究的目的是确定甲状腺切除术的时机如何影响术后体重变化。方法:我们进行了两机构研究,确定接受全甲状腺切除术治疗甲状腺功能亢进的患者。如果将患者作为第一治疗选择进行手术,则将其分类为“早期”;如果先前接受放射性碘(RAI)的治疗,则为“延迟”。在适当的情况下,将各组与学生的t检验或χ2检验进行比较。结果:204例患者因甲状腺功能亢进而接受甲状腺切除术。在这些患者中,有171例被归类为早期,33例被归类为延迟。总体而言,患者在最后一次随访时体重增加了术前体重的6.0%±0.8。两组之间的术前体重指数(BMI)相似(p = 0.98),中位随访时间为388天(范围15-1584天)。两组均增加体重,直到术后达到正常的甲状腺刺激激素(TSH)为止。在达到正常的TSH后,早期组稳定或减轻体重(-0.2磅/天),而延迟组继续增加体重(0.02磅/天; p = 0.61)。在最后一次随访中,与早期组相比,延迟组中增加BMI类别的患者明显更多(42.4比21.6%; p = 0.01)。与早期组相比,延迟组中上升或进入不健康BMI类别(超重或肥胖)的患者是后者的两倍(39.4比19.3%; p = 0.01)。结论:与最初接受RAI治疗的患者相比,以外科手术作为首次治疗的甲状腺功能亢进症患者术后超重或肥胖的可能性较小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号